# City of Hope Medical Center: Phase 1 study withdrawn (Sickle Cell Disease)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | City of Hope Medical Center |
| Sponsor type | Academic and hospital |
| Study | Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease |
| NCT ID | NCT03279094 |
| Phase | Phase 1 |
| Status | withdrawn |
| Conditions | Sickle Cell Disease |
| Intervention types | biological |
| Posted | 2017-09-12 |
| Planned start | 2018-02-02 |
| Event | Withdrawn before enrolling |
| Event date | 2026-10-26 |
| Last update posted | 2026-10-26 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT03279094). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.